1. Home
  2. HOV vs ZVRA Comparison

HOV vs ZVRA Comparison

Compare HOV & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hovnanian Enterprises Inc.

HOV

Hovnanian Enterprises Inc.

HOLD

Current Price

$133.70

Market Cap

645.8M

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$13.59

Market Cap

741.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOV
ZVRA
Founded
1959
2006
Country
United States
United States
Employees
1891
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
645.8M
741.9M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
HOV
ZVRA
Price
$133.70
$13.59
Analyst Decision
Sell
Strong Buy
Analyst Count
2
5
Target Price
$97.00
$23.00
AVG Volume (30 Days)
114.6K
1.8M
Earning Date
05-19-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
159.21
EPS
N/A
0.60
Revenue
N/A
$106,470,000.00
Revenue This Year
N/A
$37.27
Revenue Next Year
$5.96
$53.42
P/E Ratio
$17.50
$23.30
Revenue Growth
N/A
350.91
52 Week Low
$91.52
$7.16
52 Week High
$162.06
$14.58

Technical Indicators

Market Signals
Indicator
HOV
ZVRA
Relative Strength Index (RSI) 58.11 64.82
Support Level $97.80 $8.26
Resistance Level N/A $14.27
Average True Range (ATR) 8.22 0.60
MACD 0.71 0.06
Stochastic Oscillator 57.05 75.00

Price Performance

Historical Comparison
HOV
ZVRA

About HOV Hovnanian Enterprises Inc.

Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations. The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments: Northeast, which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia; Southeast, which includes Florida, Georgia, and South Carolina; and West, which includes Arizona, California, and Texas. The firm generates maximum revenue from the West Segment.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: